Notice: This company has been marked as potentially delisted and may not be actively trading. Elicio Therapeutics (ELTX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Elicio Therapeutics Short Interest DataElicio Therapeutics (ELTX) has a short interest of 39,400 shares, representing 0.48% of the float (the number of shares available for trading by the public). This marks a 31.33% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 16,135 shares to cover all short positions.Current Short Interest39,400 sharesPrevious Short Interest30,000 sharesChange Vs. Previous Month+31.33%Dollar Volume Sold Short$198,182.00Short Interest Ratio2.1 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares10,770,000 sharesFloat Size8,160,000 sharesShort Percent of Float0.48%Today's Trading Volume22,706 sharesAverage Trading Volume16,135 sharesToday's Volume Vs. Average141% Short Selling Elicio Therapeutics? Sign up to receive the latest short interest report for Elicio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELTX Short Interest Over TimeELTX Days to Cover Over TimeELTX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingBillionaires Spot Once-In-25-Year Wealth OpportunityWhy November 7th Will Impact Stocks More Than The Election Just 48 hours after the 2024 Presidential Election… A man from a completely different government branch is going to stand up, say a few words… and make history in the stock market. Click here for the full story. Elicio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/202439,400 shares $198,182.00 +31.3%0.5%2.1 $5.03 9/15/202430,000 shares $125,550.00 -30.2%0.4%0.9 $4.19 8/31/202443,000 shares $163,400.00 No Change0.5%1.3 $3.80 8/15/202443,000 shares $185,330.00 -35.5%0.5%1.2 $4.31 7/31/202466,700 shares $345,506.00 -11.8%0.8%1.4 $5.18 7/15/202475,600 shares $321,300.00 +11.3%0.9%1.5 $4.25 6/30/202467,900 shares $279,069.00 -10.4%0.9%1.2 $4.11 6/15/202475,800 shares $619,286.00 -8.6%1.0%1.6 $8.17 5/31/202482,900 shares $654,910.00 -8.3%1.1%1.4 $7.90 5/15/202490,400 shares $940,160.00 +5.9%1.2%1.5 $10.40 4/30/202485,400 shares $785,680.00 +38.0%1.2%1.5 $9.20 4/15/202461,900 shares $571,337.00 +56.7%0.9%1 $9.23 3/31/202439,500 shares $300,200.00 +39.1%0.6%0.3 $7.60 3/15/202428,400 shares $142,000.00 +20.9%0.5%0.2 $5.00 2/29/202423,500 shares $95,410.00 -23.5%0.4%0.2 $4.06 2/15/202430,700 shares $128,326.00 -35.9%0.5%0.3 $4.18 1/31/202447,900 shares $210,760.00 No Change0.8%0.5 $4.40 ELTX Short Interest - Frequently Asked Questions What is Elicio Therapeutics' current short interest? Short interest is the volume of Elicio Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 39,400 shares of ELTX short. 0.48% of Elicio Therapeutics' shares are currently sold short. Learn More on Elicio Therapeutics' current short interest. What is a good short interest ratio for Elicio Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTX shares currently have a short interest ratio of 2.0. Learn More on Elicio Therapeutics's short interest ratio. What is a good short interest percentage for Elicio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.48% of Elicio Therapeutics' floating shares are currently sold short. Is Elicio Therapeutics' short interest increasing or decreasing? Elicio Therapeutics saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 39,400 shares, an increase of 31.3% from the previous total of 30,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Elicio Therapeutics' float size? Elicio Therapeutics currently has issued a total of 10,770,000 shares. Some of Elicio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Elicio Therapeutics currently has a public float of 8,160,000 shares. How does Elicio Therapeutics' short interest compare to its competitors? 0.48% of Elicio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Elicio Therapeutics: Nkarta, Inc. (19.10%), Corbus Pharmaceuticals Holdings, Inc. (22.28%), Rezolute, Inc. (2.69%), Galecto, Inc. (1.41%), Organigram Holdings Inc. (3.31%), DiaMedica Therapeutics Inc. (0.36%), Atossa Therapeutics, Inc. (10.28%), Ventyx Biosciences, Inc. (15.65%), Greenwich LifeSciences, Inc. (8.37%), Forte Biosciences, Inc. (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short Elicio Therapeutics stock? Short selling ELTX is an investing strategy that aims to generate trading profit from Elicio Therapeutics as its price is falling. ELTX shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elicio Therapeutics? A short squeeze for Elicio Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTX, which in turn drives the price of the stock up even further. How often is Elicio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTX, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies Nkarta Short Interest Data Corbus Pharmaceuticals Short Interest Data Rezolute Short Interest Data Galecto Short Interest Data Organigram Short Interest Data DiaMedica Therapeutics Short Interest Data Atossa Therapeutics Short Interest Data Ventyx Biosciences Short Interest Data Greenwich LifeSciences Short Interest Data Forte Biosciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELTX) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elicio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elicio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.